HomeTBPH • NASDAQ
add
Theravance Biopharma Inc
Previous close
$14.90
Day range
$14.95 - $15.36
Year range
$7.90 - $21.03
Market cap
787.33M USD
Avg Volume
830.97K
P/E ratio
7.44
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 45.89M | 144.70% |
Operating expense | 18.52M | 0.10% |
Net income | 61.02M | 493.02% |
Net profit margin | 132.98 | 260.62% |
Earnings per share | 0.06 | 217.76% |
EBITDA | 20.41M | 332.51% |
Effective tax rate | 16.48% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 315.36M | 256.94% |
Total assets | 485.57M | 37.10% |
Total liabilities | 188.85M | 5.73% |
Total equity | 296.72M | — |
Shares outstanding | 51.49M | — |
Price to book | 2.56 | — |
Return on assets | 11.10% | — |
Return on capital | 16.22% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 61.02M | 493.02% |
Cash from operations | -6.06M | -572.28% |
Cash from investing | 588.00K | -96.25% |
Cash from financing | -1.49M | -308.49% |
Net change in cash | -6.97M | -148.32% |
Free cash flow | -59.10M | -32.80% |
About
Founded
2013
Website
Employees
90
